149 related articles for article (PubMed ID: 2219974)
1. Benign proliferative disorders of the breast.
Ahn HJ; Cho NH; Yang WI; Choi IJ
Yonsei Med J; 1990 Jun; 31(2):168-73. PubMed ID: 2219974
[TBL] [Abstract][Full Text] [Related]
2. Histopathology of myoepithelial (basocellular) hyperplasias in adenosis and epitheliosis of the breast demonstrated by the reactivity of cytokeratins and S100 protein. An analysis of heterogenic cell proliferations in 90 cases of benign and malignant breast diseases.
Bässler R; Katzer B
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):435-42. PubMed ID: 1280883
[TBL] [Abstract][Full Text] [Related]
3. [Significance of proliferative breast lesions around breast cancers].
Moriya T; Manabe T; Sakurai T; Sakamoto K
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():42-5. PubMed ID: 7747991
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
[TBL] [Abstract][Full Text] [Related]
5. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
[TBL] [Abstract][Full Text] [Related]
6. Fine needle aspiration cytology of benign breast lumps: a review of experience with 651 cases.
Jayaram G; Gupta M
Malays J Pathol; 1994 Jun; 16(1):29-38. PubMed ID: 16329573
[TBL] [Abstract][Full Text] [Related]
7. Subclassification of benign breast disease by fine needle aspiration cytology. Comparison of cytologic and histologic findings in 265 palpable breast masses.
Maygarden SJ; Novotny DB; Johnson DE; Frable WJ
Acta Cytol; 1994; 38(2):115-29. PubMed ID: 8147200
[TBL] [Abstract][Full Text] [Related]
8. Fibrocystic change and fibrocystic disease of the breast.
Drukker BH; deMendonca WC
Obstet Gynecol Clin North Am; 1987 Sep; 14(3):685-702. PubMed ID: 3323971
[TBL] [Abstract][Full Text] [Related]
9. Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast.
Jacquemier JD; Rolland PH; Vague D; Lieutaud R; Spitalier JM; Martin PM
Cancer; 1982 Jun; 49(12):2534-6. PubMed ID: 7074570
[TBL] [Abstract][Full Text] [Related]
10. The patho-epidemiology of benign proliferative epithelial disorders of the female breast.
Cook MG; Rohan TE
J Pathol; 1985 May; 146(1):1-15. PubMed ID: 3891937
[TBL] [Abstract][Full Text] [Related]
11. [Morphology of dysplasia and small cancer of the breast].
Ermilova VD; Zolotarevskiĭ VB; Delektorskaia VV; Raĭkhlin NT
Arkh Patol; 1985; 47(11):43-51. PubMed ID: 3004395
[TBL] [Abstract][Full Text] [Related]
12. Benign breast disease and the risk of breast cancer in the next 15 years.
Socolov D; Anghelache I; Ilea C; Socolov R; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):135-40. PubMed ID: 25970956
[TBL] [Abstract][Full Text] [Related]
13. [Morphometric analysis of fibrocystic breast disease].
Guski H; Freitag A; Hufnagl P; Voss K; Wenzelides K; Simon H
Zentralbl Allg Pathol; 1986; 132(4):293-300. PubMed ID: 3026118
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study.
Bartow SA; Pathak DR; Black WC; Key CR; Teaf SR
Cancer; 1987 Dec; 60(11):2751-60. PubMed ID: 3677009
[TBL] [Abstract][Full Text] [Related]
15. [Fibrocystic disease of the breast in autopsy cases with special reference to the age frequency distribution of epithelial hyperplasia and its relation to liver cirrhosis].
Suehiro S; Inai K; Tokuoka S
Gan No Rinsho; 1986 Oct; 32(12):1525-32. PubMed ID: 3783977
[TBL] [Abstract][Full Text] [Related]
16. Caffeine consumption and fibrocystic breast disease: a case-control epidemiologic study.
Boyle CA; Berkowitz GS; LiVolsi VA; Ort S; Merino MJ; White C; Kelsey JL
J Natl Cancer Inst; 1984 May; 72(5):1015-9. PubMed ID: 6585579
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for breast cancer in women with proliferative breast disease.
Dupont WD; Page DL
N Engl J Med; 1985 Jan; 312(3):146-51. PubMed ID: 3965932
[TBL] [Abstract][Full Text] [Related]
18. Atypical hyperplasia, proliferative fibrocystic change, and exogenous hormone use.
Zera RT; Danielson D; Van Camp JM; Schmidt-Steinbrunn B; Hong J; McCoy M; Anderson WR; Linzie BM; Rodriguez JL
Surgery; 2001 Oct; 130(4):732-7. PubMed ID: 11602905
[TBL] [Abstract][Full Text] [Related]
19. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
[TBL] [Abstract][Full Text] [Related]
20. Mucocele-like lesions of the breast: a clinical outcome and histologic analysis of 102 cases.
Meares AL; Frank RD; Degnim AC; Vierkant RA; Frost MH; Hartmann LC; Winham SJ; Visscher DW
Hum Pathol; 2016 Mar; 49():33-8. PubMed ID: 26826407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
